-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Cadrenal Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2022 to Q3 2025.
- Cadrenal Therapeutics, Inc. Depreciation for the quarter ending September 30, 2025 was $401.000, a 1.47% decline year-over-year.
- Cadrenal Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2025 was $6.73K, a 225% increase year-over-year.
- Cadrenal Therapeutics, Inc. annual Depreciation for 2024 was $1.88K, a 5.05% decline from 2023.
- Cadrenal Therapeutics, Inc. annual Depreciation for 2023 was $1.98K, a 56.4% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)